Skip to main navigation
Lion Biotechnologies
  • About
    • About Iovance Biotherapeutics
    • Management Team
    • Board of Directors
    • Research Partners
  • Our Technology
    • About TIL
    • Application of TIL
    • Publication and Scientific Presentations
  • Clinical
    • Clinical Program
    • Clinical Pipeline
    • Unmet Medical Need
    • Metastatic Melanoma
    • Squamous Cell Carcinoma of the Head and Neck (SCCHN)
    • Cervical Carcinoma
    • Non Small Cell Lung Cancer (NSCLC)
  • Investors
    • Investor Overview
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Ownership Summary
      • Analyst Coverage
    • News & Events
      • Press Releases
      • Investor Calendar
      • Presentations
    • Financial Information
      • SEC Filings
      • Financial Reports
      • Quarterly Results
      • Earnings Estimates
    • Fundamentals
      • Snapshot
      • Trading Statistics
      • Balance Sheet
      • Income Statement
      • Cash Flow
      • Ratios
    • Corporate Governance
      • Governance Highlights
      • Committee Composition
    • Investor Resources
      • Corporate Profile
      • Information Request
      • E-mail Alerts
      • IR Contacts
  • Careers
    • Why Iovance?
    • Current Job Openings
  • Patients
  • News
  • Contact

About Lion Biotech

Home Investors Governance Highlights

Governance Highlights

Governance Highlights

Governance Documents
Audit Committee Charter 36.6 KB
Code of Conduct and Ethics 97.8 KB
Nominating and Corporate Governance Committee Charter 33.1 KB
  • Investor Toolkit
  • Print Page
  • RSS
  • E-mail Alerts
  • Home
    • hidden
  • About
  • Our Technology
  • Clinical
  • Investors
  • Careers

© 2020 Iovance Biotherapeutics, Inc All Rights Reserved.

  • Privacy Policy
  • Disclaimer
  • Sitemap